Skip to main content
Jessica Domitrovic, MD, Family Medicine, Orange Park, FL, HCA Florida Orange Park Hospital

JessicaDomitrovicMD

Family Medicine Orange Park, FL

Family Medicine Resident Physician

Dr. Domitrovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Domitrovic's full profile

Already have an account?

Education & Training

  • HCA Healthcare/Mercer University School of Medicine/Orange Park Medical Center
    HCA Healthcare/Mercer University School of Medicine/Orange Park Medical CenterResidency, Family Medicine, 2021 - 2024
  • Texas A&M; Health Science Center College of Medicine
    Texas A&M; Health Science Center College of MedicineClass of 2021, MD

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - 2025

Publications & Presentations

Journal Articles

  • Inhibition of Toll-like Receptor 4 and the NLPR3 Inflammasome as Potential Treatments for Acute Respiratory Distress Syndrome  
    Jessica Domitrovic, Proceedings of the Texas A&M Medical Student Grand Rounds, 7/2018
  • Effectiveness of atorvastatin calcium on inhibition of biofilm production by Kocuria rhizophila and Mycobacterium smegmatis  
    Domitrovic, Jessica; Reid, Chelsea, Writing Across the Curriculum, 2015

Abstracts/Posters

  • Challenges Involved in the Treatment of Hospitalized COVID Patients with Severe Mental Illness
    Jessica P. Domitrovic, Christine Barr MSW, Linda Barloon Psych NP, Ranjit C. Chacko MD, American Psychiatric Association 2021 Annual Meeting, online poster hall, 5/1/2021
  • Modeling peritoneal volume and surface area to inform chemotherapeutic dosing in HIPEC
    Domitrovic, J.P., Milosevic, M.; Kojik, M.; Holder, A.M., Texas A&M College of Medicine Medical Research Colloquium 2020, Round Rock, TX, 2/26/2020

Authored Content

  • Inhibition of Toll-like Receptor 4 & the NLPR3 Inflammasome as Potential Treatments for Acute Respiratory Distress SyndromeMay 2018

Professional Memberships

Hospital Affiliations